Department of Surgery, Welfare District of Forssa, Forssa, Finland.
Department of Orthopaedics and Traumatology, Turku University Hospital, Kiinamyllynkatu 4-8, 20521, Turku, Finland.
Eur J Orthop Surg Traumatol. 2023 Aug;33(6):2611-2617. doi: 10.1007/s00590-023-03481-6. Epub 2023 Feb 2.
Platelet-rich plasma (PRP) injections are challenging the current treatment options for knee osteoarthritis (KOA). Targeting the treatment to optimal stage of the symptomatic KOA may be crucial in the success and failure of treatment. The aim of this study is to compare the outcomes of PRP injections at different stages of KOA in order to determine the optimal stage of the KOA for PRP injection treatments.
A total of 89 consecutive patients with symptomatic KOA Kellgren-Lawrence grade 1 to 3 (Group A grade 1, group B grade 2 and group C grade 3) were given three intra-articular injections of PRP with 2 weeks interval between injections. Visual Analogue Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Range of Motion were measured before injection, at 15 days, 6 months, 12 months and, at last follow-up. Intergroup outcomes were compared.
The comparison of groups A and C showed that WOMAC scores were significantly higher in group C at 15 days [p = 0.047] and at last follow-up [p = 0.008] than in group A, as well as VAS scores at 6 months [p = 0.031] and at last follow-up [p = 0.008]. The overall WOMAC and VAS scores showed decrease in all the groups in minimum follow-up of 14 months. The other comparisons did not show significant differences in outcomes.
All the groups showed decrease in WOMAC and VAS, but patients with mild KOA benefit significantly more from the treatments than patients with more severe KOA.
富含血小板的血浆 (PRP) 注射正在挑战膝骨关节炎 (KOA) 的当前治疗选择。针对 KOA 症状的最佳阶段进行治疗可能是治疗成功与失败的关键。本研究旨在比较 KOA 不同阶段 PRP 注射的结果,以确定 KOA 进行 PRP 注射治疗的最佳阶段。
共纳入 89 例连续的有症状 KOA(Kellgren-Lawrence 分级 1 至 3 级)患者(A 组为 1 级,B 组为 2 级,C 组为 3 级),每 2 周注射 3 次关节内 PRP。在注射前、注射后 15 天、6 个月、12 个月和末次随访时测量视觉模拟量表 (VAS)、西安大略和麦克马斯特大学骨关节炎指数 (WOMAC) 和关节活动度。比较组间结果。
A 组和 C 组比较显示,C 组在 15 天 [p=0.047] 和末次随访时 [p=0.008] 的 WOMAC 评分明显高于 A 组,6 个月 [p=0.031] 和末次随访时 [p=0.008] 的 VAS 评分也明显高于 A 组。所有组在至少 14 个月的随访中,WOMAC 和 VAS 的总体评分均下降。其他比较在结果上无显著差异。
所有组的 WOMAC 和 VAS 评分均下降,但轻度 KOA 患者从治疗中获益明显多于重度 KOA 患者。